Apogee Therapeutics
APGE
APGE
182 hedge funds and large institutions have $2.51B invested in Apogee Therapeutics in 2025 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 55 increasing their positions, 65 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8.01% less ownership
Funds ownership: 133.61% → 125.6% (-8%)
15% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 65
46% less call options, than puts
Call options by funds: $18.5M | Put options by funds: $34.4M
Holders
182
Holding in Top 10
5
Calls
$18.5M
Puts
$34.4M
Top Buyers
| 1 | +$31.9M | |
| 2 | +$21.4M | |
| 3 | +$17.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$16.3M |
| 5 |
Goldman Sachs
New York
|
+$14M |
Top Sellers
| 1 | -$63.9M | |
| 2 | -$58.6M | |
| 3 | -$48.9M | |
| 4 |
Mercer Global Advisors
Denver,
Colorado
|
-$31.2M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$22.6M |